User menu

Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates.

Bibliographic reference Charretier, Yannick ; Köhler, Thilo ; Cecchini, Tiphaine ; Bardet, Chloé ; Cherkaoui, Abdessalam ; et. al. Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates.. In: Frontiers in Microbiology, Vol. 6, no. 10, p. 81 [1-10] (2015)
Permanent URL
  1. Aires, Antimicrob. Agents Chemother, 43, 2624 (1999)
  2. Altschul Stephen F., Gish Warren, Miller Webb, Myers Eugene W., Lipman David J., Basic local alignment search tool, 10.1016/s0022-2836(05)80360-2
  3. Bisbe J., Gatell J. M., Puig J., Mallolas J., Martinez J. A., Jimenez de Anta M. T., Soriano E., Pseudomonas aeruginosa Bacteremia: Univariate and Multivariate Analyses of Factors Influencing the Prognosis in 133 Episodes, 10.1093/clinids/10.3.629
  4. Cabot G., Ocampo-Sosa A. A., Tubau F., Macia M. D., Rodriguez C., Moya B., Zamorano L., Suarez C., Pena C., Martinez-Martinez L., Oliver A., , Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study, 10.1128/aac.01645-10
  5. Domon Bruno, Aebersold Ruedi, Options and considerations when selecting a quantitative proteomics strategy, 10.1038/nbt.1661
  6. Dumas Jean-Luc, Delden Christian, Perron Karl, Köhler Thilo, Analysis of antibiotic resistance gene expression inPseudomonas aeruginosaby quantitative real-time-PCR, 10.1111/j.1574-6968.2005.00008.x
  7. Duncan Mark W, Aebersold Ruedi, Caprioli Richard M, The pros and cons of peptide-centric proteomics, 10.1038/nbt0710-659
  8. Giamarellou Helen, Kanellakopoulou Kyriaki, Current Therapies for Pseudomonas Aeruginosa, 10.1016/j.ccc.2007.12.004
  9. Hocquet D., Berthelot P., Roussel-Delvallez M., Favre R., Jeannot K., Bajolet O., Marty N., Grattard F., Mariani-Kurkdjian P., Bingen E., Husson M.-O., Couetdic G., Plesiat P., Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections, 10.1128/aac.00503-07
  10. Hocquet D., Roussel-Delvallez M., Cavallo J.-D., Plesiat P., MexAB-OprM- and MexXY-Overproducing Mutants Are Very Prevalent among Clinical Strains of Pseudomonas aeruginosa with Reduced Susceptibility to Ticarcillin, 10.1128/aac.01334-06
  11. Hosaka M., Gotoh N., Nishino T., Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ, 10.1128/aac.39.8.1731
  12. Jalal S., Ciofu O., Hoiby N., Gotoh N., Wretlind B., Molecular Mechanisms of Fluoroquinolone Resistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients, 10.1128/aac.44.3.710-712.2000
  13. Köhler, J. Bacteriol, 181, 6300 (1999)
  14. Kohler Thilo, Michea-Hamzehpour Mehri, Henze Uta, Gotoh Naomasa, Kocjancic Curty Lasta, Pechere Jean-Claude, Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa, 10.1046/j.1365-2958.1997.2281594.x
  15. Lange Vinzenz, Picotti Paola, Domon Bruno, Aebersold Ruedi, Selected reaction monitoring for quantitative proteomics: a tutorial, 10.1038/msb.2008.61
  16. Lister P. D., Wolter D. J., Hanson N. D., Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms, 10.1128/cmr.00040-09
  17. Livermore, Clin. Microbiol. Rev, 8, 557 (1995)
  18. Livermore D. M., Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?, 10.1086/338782
  19. Lyczak Jeffrey B, Cannon Carolyn L, Pier Gerald B, Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist1*Address for correspondence: Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA, 10.1016/s1286-4579(00)01259-4
  20. MacLean Brendan, Tomazela Daniela M., Shulman Nicholas, Chambers Matthew, Finney Gregory L., Frewen Barbara, Kern Randall, Tabb David L., Liebler Daniel C., MacCoss Michael J., Skyline: an open source document editor for creating and analyzing targeted proteomics experiments, 10.1093/bioinformatics/btq054
  21. Martinez-Ramos I., Mulet X., Moya B., Barbier M., Oliver A., Alberti S., Overexpression of MexCD-OprJ Reduces Pseudomonas aeruginosa Virulence by Increasing Its Susceptibility to Complement-Mediated Killing, 10.1128/aac.02012-13
  22. Masuda N., Sakagawa E., Ohya S., Gotoh N., Tsujimoto H., Nishino T., Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in Pseudomonas aeruginosa, 10.1128/aac.44.12.3322-3327.2000
  23. McAlister Graeme C., Huttlin Edward L., Haas Wilhelm, Ting Lily, Jedrychowski Mark P., Rogers John C., Kuhn Karsten, Pike Ian, Grothe Robert A., Blethrow Justin D., Gygi Steven P., Increasing the Multiplexing Capacity of TMTs Using Reporter Ion Isotopologues with Isobaric Masses, 10.1021/ac301572t
  24. Micek S. T., Lloyd A. E., Ritchie D. J., Reichley R. M., Fraser V. J., Kollef M. H., Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment, 10.1128/aac.49.4.1306-1311.2005
  25. Mine, Antimicrob. Agents Chemother, 43, 415 (1999)
  26. Morita Yuji, Tomida Junko, Kawamura Yoshiaki, MexXY multidrug efflux system of Pseudomonas aeruginosa, 10.3389/fmicb.2012.00408
  27. Mueller-Ortiz S. L., Drouin S. M., Wetsel R. A., The Alternative Activation Pathway and Complement Component C3 Are Critical for a Protective Immune Response against Pseudomonas aeruginosa in a Murine Model of Pneumonia, 10.1128/iai.72.5.2899-2906.2004
  28. Pfaffl M. W., Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR, 10.1093/nar/30.9.e36
  29. Picotti Paola, Bodenmiller Bernd, Mueller Lukas N., Domon Bruno, Aebersold Ruedi, Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics, 10.1016/j.cell.2009.05.051
  30. Pirnay Jean-Paul, Vos Daniel De, Mossialos Dimitris, Vanderkelen Alain, Cornelis Pierre, Zizi Martin, Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates, 10.1046/j.1462-2920.2002.00281.x
  31. Poole Keith, Pseudomonas Aeruginosa: Resistance to the Max, 10.3389/fmicb.2011.00065
  32. Poole Keith, Gotoh Naomasa, Tsujimoto Hideto, Zhao Qixun, Wada Akihisa, Yamasaki Tetsuo, Neshat Shadi, Yamagishi Jun-ichi, Li Xian-Zhi, Nishino Takeshi, Overexpression of themexC-mexD-oprJefflux operon innfxB-type multidrug-resistant strains ofPseudomonas aeruginosa, 10.1046/j.1365-2958.1996.281397.x
  33. Poole K, Krebes K, McNally C, Neshat S, Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon., 10.1128/jb.175.22.7363-7372.1993
  34. Rau, Environ. Microbiol, 12, 1643 (2010)
  35. Ruijter J. M., Ramakers C., Hoogaars W. M. H., Karlen Y., Bakker O., van den Hoff M. J. B., Moorman A. F. M., Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data, 10.1093/nar/gkp045
  36. Shilov Ignat V., Seymour Sean L., Patel Alpesh A., Loboda Alex, Tang Wilfred H., Keating Sean P., Hunter Christie L., Nuwaysir Lydia M., Schaeffer Daniel A., The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra, 10.1074/mcp.t600050-mcp200
  37. Tabb David L., Vega-Montoto Lorenzo, Rudnick Paul A., Variyath Asokan Mulayath, Ham Amy-Joan L., Bunk David M., Kilpatrick Lisa E., Billheimer Dean D., Blackman Ronald K., Cardasis Helene L., Carr Steven A., Clauser Karl R., Jaffe Jacob D., Kowalski Kevin A., Neubert Thomas A., Regnier Fred E., Schilling Birgit, Tegeler Tony J., Wang Mu, Wang Pei, Whiteaker Jeffrey R., Zimmerman Lisa J., Fisher Susan J., Gibson Bradford W., Kinsinger Christopher R., Mesri Mehdi, Rodriguez Henry, Stein Stephen E., Tempst Paul, Paulovich Amanda G., Liebler Daniel C., Spiegelman Cliff, Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry, 10.1021/pr9006365
  38. Tiwari Vishvanath, Tiwari Monalisa, Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii, 10.3389/fmicb.2014.00512
  39. Trias J, Nikaido H, Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa., 10.1128/aac.34.1.52
  40. Trias, J. Biol. Chem, 265, 15680 (1990b)
  41. Untergasser Andreas, Cutcutache Ioana, Koressaar Triinu, Ye Jian, Faircloth Brant C., Remm Maido, Rozen Steven G., Primer3—new capabilities and interfaces, 10.1093/nar/gks596
  42. Vandesompele Jo, De Preter Katleen, Pattyn Filip, Poppe Bruce, Van Roy Nadine, De Paepe Anne, Speleman Frank, 10.1186/gb-2002-3-7-research0034
  43. Vogne C., Aires J. R., Bailly C., Hocquet D., Plesiat P., Role of the Multidrug Efflux System MexXY in the Emergence of Moderate Resistance to Aminoglycosides among Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis, 10.1128/aac.48.5.1676-1680.2004
  44. Wang Jie, Zhou Jian-ying, Qu Ting-ting, Shen Ping, Wei Ze-qing, Yu Yun-song, Li Lan-juan, Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals, 10.1016/j.ijantimicag.2009.12.014
  45. Worboys Jonathan D, Sinclair John, Yuan Yinyin, Jørgensen Claus, Systematic evaluation of quantotypic peptides for targeted analysis of the human kinome, 10.1038/nmeth.3072